CoChat

Sodium Glucose Cotransporter-2 Inhibition and Cardiorenal Protection

Open access
Cherney, David Z., Odutayo, Ayodele, Aronson, Ronnie, Ezekowitz, Justin, Parker, John D. · 2019 · Journal of the American College of Cardiology
Cited by 81

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Abstract

Poorly controlled type 2 diabetes mellitus is associated with the development of cardiovascular and renal complications, resulting in significant morbidity and mortality. Intensive glycemic control has been a major focus for clinical trials and novel drug development. However, narrow treatment strategies developed strictly for glycemic control did not confer a large risk reduction in cardiovascular events. There were also only modest effects in reducing the progression of diabetic kidney disease. Recent cardiovascular safety trials and the dedicated renal protection trial CREDENCE (Canagliflozin on Renal and Cardiovascular Outcomes in Participants with Diabetic Nephropathy) have shown that the sodium-glucose cotransporter-2 (SGLT2) inhibitors, a newer generation of antihyperglycemic agents, improve both cardiovascular and renal outcomes when added to guideline-recommended treatment. This review examines the current evidence on the mechanism underlying the cardiorenal effects of SGLT2 inhibitors and summarizes clinical trial evidence and safety data related to the use of SGLT2 inhibitors for cardiovascular and renal protection.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2019.09.022

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 23 references

Cited by

See all 81

Metadata

Authors
Cherney, D. Z., Odutayo, A., Aronson, R., Ezekowitz, J., & Parker, J. D.
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2019-11
Volume
74
Issue
20
Pages
2511-2524
ISSN
0735-1097 (ISSN-L)
OpenAlex
W2984471300
Cited by
81
References
23
FWCI
6.37
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Sodium Glucose Cotransporter-2 Inhibition and Cardiorenal Protection. https://app.cochat.ai/papers/10.1016/j.jacc.2019.09.022
The paper
Cherney, D. Z., Odutayo, A., Aronson, R., Ezekowitz, J., & Parker, J. D. (2019). Sodium Glucose Cotransporter-2 Inhibition and Cardiorenal Protection. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2019.09.022

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.